Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the local anesthetic bupivacaine delivered
intrathecally in small doses via PTM self-administered boluses significantly improves the
breakthrough pain and functional status of patients with chronic intractable pain who are
managed with an intrathecal drug delivery system.